ResearcherUniversity of Campania "Luigi Vanvitelli"No recent work listed
Annalisa Pappalardo
Matched on OpenAlex author ID A5108920225. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2019: 1 paper · 2020: 1 paper · 2021: 1 paper
Papers 3
- Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. Co-author DOI 10.3389/fonc.2021.695627↗
- Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis. Co-author DOI 10.3390/ijms21082814↗
- Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment. First author DOI 10.1007/s12032-019-1306-9↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Luca Pompella · 3 shared papers, 2019–2021 · strength 0.34
- Paper Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. DOI 10.3389/fonc.2021.695627↗
- Paper Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis. DOI 10.3390/ijms21082814↗
- Paper Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabi… DOI 10.1007/s12032-019-1306-9↗
- Ferdinando De Vita · 3 shared papers, 2019–2021 · strength 0.34
- Paper Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. DOI 10.3389/fonc.2021.695627↗
- Paper Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis. DOI 10.3390/ijms21082814↗
- Paper Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabi… DOI 10.1007/s12032-019-1306-9↗
- Angelica Petrillo · 2 shared papers, 2019–2021 · strength 0.22
- Michele Orditura · 2 shared papers, 2019–2020 · strength 0.20
- Fortunato Ciardiello · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.